Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel Monotherapy in Untreated Focal Onset Seizures
NCT05533814Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2022
- Primary completion
- Jan 2025
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of perampanel in focal onset seizure, sponsored by Eisai Co., Ltd.. Started Oct 2022; status: completed.
02
Drugs
perampanel
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT05533814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05533814.